Leveraging WHO’s Global Benchmarking Tool to strengthen capacity in clinical trials oversight for public health emergencies admin June 29, 2022 To open the publication please click the link below. admin See author's posts Continue Reading Previous: Challenging the “old boys club” in academia: Gender and geographic representation in editorial boards of journals publishing in environmental sciences and public healthNext: Long-term survival benefit of male and multimorbid COVID-19 patients with 5-day remdesivir treatment Related Stories Cancer burden and status of cancer control measures in fragile states: acomparative analysis of 31 countries Cancer burden and status of cancer control measures in fragile states: acomparative analysis of 31 countries October 3, 2022 Children with COVID-19 have a substantially higher risk of developing type1 diabetes in the months following diagnosis, according to a newstudy analyzing health records of 1 million+ patients 18 and under; but it’sunclear whether COVID-19 itself triggers diabetes onset Children with COVID-19 have a substantially higher risk of developing type1 diabetes in the months following diagnosis, according to a newstudy analyzing health records of 1 million+ patients 18 and under; but it’sunclear whether COVID-19 itself triggers diabetes onset October 3, 2022 Reasons for informal payments from the perspective of health careproviders and recipients: a qualitative study in Iran Reasons for informal payments from the perspective of health careproviders and recipients: a qualitative study in Iran October 3, 2022
